Arylcyclopropylacetamide derivatives useful as glucokinase activators

Details for Australian Patent Application No. 2009335931 (hide)

Owner Eli Lilly and Company

Inventors Bueno Melendo, Ana Belen; AgejasChicharro, Francisco Javier

Agent Spruson & Ferguson

Pub. Number AU-B-2009335931

PCT Pub. Number WO2010/080333

Priority 08380341.1 19.12.08 EP; 61/153,781 19.02.09 US

Filing date 11 December 2009

Wipo publication date 15 July 2010

Acceptance publication date 31 May 2012

International Classifications

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/080333 Priority application(s): WO2010/080333

31 May 2012 Application Accepted

  Published as AU-B-2009335931

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335949-Constant force intraocular lens injector

2009335928-Correction of peripheral defocus of an eye and control of refractive error development